- Home
- ESQ vs KROS Comparison
ESQ vs KROS Comparison
Compare ESQ & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESQ
- KROS
- Stock Information
- Founded
- ESQ 2006
- KROS 2015
- Country
- ESQ United States
- KROS United States
- Employees
- ESQ N/A
- KROS N/A
- Industry
- ESQ Commercial Banks
- KROS Biotechnology: Pharmaceutical Preparations
- Sector
- ESQ Finance
- KROS Health Care
- Exchange
- ESQ Nasdaq
- KROS Nasdaq
- Market Cap
- ESQ 638.2M
- KROS 589.8M
- IPO Year
- ESQ 2017
- KROS 2020
- Fundamental
- Price
- ESQ $83.24
- KROS $10.42
- Analyst Decision
- ESQ Buy
- KROS Buy
- Analyst Count
- ESQ 4
- KROS 11
- Target Price
- ESQ $70.00
- KROS $68.83
- AVG Volume (30 Days)
- ESQ 61.8K
- KROS 1.9M
- Earning Date
- ESQ 01-27-2025
- KROS 02-26-2025
- Dividend Yield
- ESQ 0.72%
- KROS N/A
- EPS Growth
- ESQ 2.35
- KROS N/A
- EPS
- ESQ 4.95
- KROS N/A
- Revenue
- ESQ $116,205,000.00
- KROS $651,000.00
- Revenue This Year
- ESQ N/A
- KROS $303.39
- Revenue Next Year
- ESQ $11.52
- KROS N/A
- P/E Ratio
- ESQ $16.73
- KROS N/A
- Revenue Growth
- ESQ 10.32
- KROS 8037.50
- 52 Week Low
- ESQ $44.45
- KROS $9.78
- 52 Week High
- ESQ $83.36
- KROS $73.00
- Technical
- Relative Strength Index (RSI)
- ESQ 63.72
- KROS 18.56
- Support Level
- ESQ $76.97
- KROS $15.59
- Resistance Level
- ESQ $82.56
- KROS $16.49
- Average True Range (ATR)
- ESQ 2.30
- KROS 0.89
- MACD
- ESQ 0.03
- KROS 0.93
- Stochastic Oscillator
- ESQ 98.12
- KROS 8.63
About ESQ Esquire Financial Holdings Inc.
Esquire Financial Holdings Inc is a full-service commercial bank dedicated to serving the financial needs of the legal industry and small businesses nationally, as well as commercial and retail customers in the New York metropolitan area. The Bank offers tailored products and solutions to the legal community and their clients as well as dynamic and flexible payment processing solutions to small business owners. Banking products offered for businesses and consumers include checking, savings, money market, and time deposits; a wide range of commercial and consumer loans, as well as customary banking services. The Bank operates a payment processing platform through third-party Independent Sales Organizations.
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.